Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014 Provided on an Intermittent Schedule for Neurofibromatosis 2 Patients With Progressive or Symptomati
Brief Summary: The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.